Cocrystal Pharma (NASDAQ:COCP) Issues Earnings Results

Posted by Brenda Bartman on May 23rd, 2026

Cocrystal Pharma (NASDAQ:COCP – Get Free Report) released its earnings results on Thursday. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.02), FiscalAI reports. The business had revenue of $0.22 million during the quarter, compared to analysts’ expectations of $0.23 million.

Cocrystal Pharma Stock Up 1.8%

Shares of COCP stock opened at $1.15 on Friday. The firm has a 50 day moving average price of $1.28 and a two-hundred day moving average price of $1.11. The company has a market capitalization of $15.86 million, a PE ratio of -1.58 and a beta of 1.50. Cocrystal Pharma has a 12-month low of $0.86 and a 12-month high of $2.67.

Hedge Funds Weigh In On Cocrystal Pharma

A hedge fund recently bought a new stake in Cocrystal Pharma stock. DRW Securities LLC purchased a new stake in Cocrystal Pharma, Inc. (NASDAQ:COCP – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 33,593 shares of the company’s stock, valued at approximately $33,000. DRW Securities LLC owned 0.24% of Cocrystal Pharma at the end of the most recent quarter. 6.72% of the stock is owned by hedge funds and other institutional investors.

About Cocrystal Pharma

(Get Free Report)

Cocrystal Pharma, Inc (NASDAQ:COCP) is a clinical-stage biotechnology company focused on the discovery and development of novel antiviral therapeutics. Utilizing an integrated structure-guided drug design platform, the company combines x-ray crystallography, computational chemistry and medicinal chemistry to identify and optimize small molecule inhibitors targeting key viral enzymes. This approach is intended to accelerate the progression of lead candidates from discovery through preclinical development.

The company’s pipeline includes multiple preclinical programs aimed at treating respiratory and systemic viral infections.